Skip to main content
. Author manuscript; available in PMC: 2010 Mar 18.
Published in final edited form as: Arch Neurol. 2009 May;66(5):646–651. doi: 10.1001/archneurol.2009.46

Table 3.

Association between clinical/neuropathological variables and superior frontal cortex MLA binding and Aβ ELISA levels

Variable MLA (N=24) Aβ40 (N=20) Aβ42 (N=20) Total Aβ (N=20)
Age -- r = 0.48, p = 0.032 r = 0.56, p = 0.011 r = 0.55, p = 0.012
Sex -- -- -- --
Education -- -- -- --
APOE ε4 -- -- -- --
MMSE (r = −0.25, p = 0.26) (r = −0.36, p = 0.12) r = −0.62, p = 0.0038 r = −0.62, p = 0.0033
PMI -- -- -- --
Braak stage (r = 0.40, p = 0.053) (r = 0.36, p = 0.12) r = 0.70, p = 0.0005 r = 0.62, p = 0.0035
NIA Reagan Dx r = −0.47, p = 0.021 r = −0.52, p = 0.020 r = −0.63, p = 0.0031 r = −0.66, p = 0.0015

r: Spearman rank correlation coefficient

--: Not statistically significant